BMY

Bristol-Myers Squibb Company ·NYSE·Healthcare
63.71 live · 2026-08-12 15:59
52.7%
Brown Bear Score
71.7%
Business Conviction Score
42.7%
Position Health Score
16.9%
Chase Risk
Daily closes

Daily closes · 1Y (252 sessions) · +36.8% · range 42.60–65.89

The Businesswhat the company reports

Business & cash flow

FCF / assets 14.3%
OCF / assets 15.7%
FCF / revenue 29.4%
Gross margin 71.7%
ROIC 16.8%
Forward P/E 9.7

FCF/assets and OCF/assets are the cash-flow measures Brown Bear's own testing found to survive; FCF/revenue is shown alongside for context. Assets are from the latest annual filing (FY2025).

Price vs Earnings growth

Forward EPS growth has outpaced trailing price return by +7.3pp

Confidence 95.0/100

Takeaway Price and forward earnings growth are broadly in step; no strong valuation lean either way.

Reported earnings

Next report 2026-10-29 · consensus EPS 1.73

Q2 23 revenue: 11.23bnQ2 23 net income: 2.07bnQ2 23 EPS: 0.99Q3 23 revenue: 10.97bnQ3 23 net income: 1.93bnQ3 23 EPS: 0.93Q3 23Q4 23 revenue: 11.48bnQ4 23 net income: 1.76bnQ4 23 EPS: 0.85Q1 24 revenue: 11.87bnQ1 24 net income: -11.91bnQ1 24 EPS: -5.89Q1 24Q2 24 revenue: 12.20bnQ2 24 net income: 1.68bnQ2 24 EPS: 0.83Q3 24 revenue: 11.89bnQ3 24 net income: 1.21bnQ3 24 EPS: 0.60Q3 24Q4 24 revenue: 12.34bnQ4 24 net income: 72.00mQ4 24 EPS: 0.04Q1 25 revenue: 11.20bnQ1 25 net income: 2.46bnQ1 25 EPS: 1.20Q1 25Q2 25 revenue: 12.27bnQ2 25 net income: 1.31bnQ2 25 EPS: 0.64Q3 25 revenue: 12.22bnQ3 25 net income: 2.20bnQ3 25 EPS: 1.08Q3 25Q4 25 revenue: 12.50bnQ4 25 net income: 1.09bnQ4 25 EPS: 0.53Q1 26 revenue: 11.49bnQ1 26 net income: 2.68bnQ1 26 EPS: 1.31Q1 26

Revenue Net incomeEPS (GAAP) (-5.89–1.31, own scale) Derived Q4

12 quarters to Q1 26. Revenue and net income share one scale, so the gap between them is the margin. The baseline is zero — bars below it are losses. The line is GAAP EPS — it spans every quarter shown, where the reported figure only goes back as far as the consensus feed does.

Quarter endingRevenueYoY Net incomeEPS (GAAP) EPS reportedvs consensus Filed
2026-03-31 11.49bn +2.6% 2.68bn 1.31 1.58 +10.4% 2026-04-30
2025-12-31 (derived) 12.50bn +1.3% 1.09bn 0.53 1.26 +11.9% 2026-02-11
2025-09-30 12.22bn +2.8% 2.20bn 1.08 1.63 +6.9% 2025-10-30
2025-06-30 12.27bn +0.6% 1.31bn 0.64 2025-07-31

Earnings response

Typical move around a filing ±3.2%
On an ordinary two days ±1.3% — filings move it 2.4× as much
Direction 5 up, 6 down over 11 filings
Revenue change and price reaction, by quarter
Q3 22 revenue -3.5% year on yearQ3 22 filed 2022-10-26: price +2.5%Q1 23 revenue -2.7% year on yearQ1 23 filed 2023-04-27: price -1.8%Q1 23Q2 23 revenue -5.6% year on yearQ2 23 filed 2023-07-27: price -3.2%Q3 23 revenue -2.2% year on yearQ3 23 filed 2023-10-26: price -9.9%Q3 23Q1 24 revenue +4.7% year on yearQ1 24 filed 2024-04-25: price -8.2%Q2 24 revenue +8.7% year on yearQ2 24 filed 2024-07-26: price +8.2%Q2 24Q3 24 revenue +8.4% year on yearQ3 24 filed 2024-10-31: price +3.2%Q1 25 revenue -5.6% year on yearQ1 25 filed 2025-04-24: price -1.3%Q1 25Q2 25 revenue +0.6% year on yearQ2 25 filed 2025-07-31: price -3.8%Q3 25 revenue +2.8% year on yearQ3 25 filed 2025-10-30: price +8.1%Q3 25Q1 26 revenue +2.6% year on yearQ1 26 filed 2026-04-30: price +1.1%

Revenue up year on year Revenue down Price move around the filing separate scales — a crossing means nothing

Quarter endingFiledRevenue YoY Move around filingNext 20 sessions vs SPY
2026-03-31 2026-04-30 +2.6% +1.1% -10.9%
2025-09-30 2025-10-30 +2.8% +8.1% +7.0%
2025-06-30 2025-07-31 +0.6% -3.8% +2.9%
2025-03-31 2025-04-24 -5.6% -1.3% -7.4%

Share count

Diluted shares over time

Diluted shares Return since the previous filing

Direction Flat — little net change
Diluted shares 2,047.0M as at 2026-03-31
Change over 1 year +0.3%
Change over 3 years -3.1%
Public float $94.19bn as at 2025-06-30 (10-K)

The Pricewhat the chart is doingTop ↑

Price Levels

StrategyFair Value Anchor
Reference band 58.27 — 64.02
Protective stop 58.48 (Structure, 4.4% risk)
Support 59.38 (4 touches, 7.3% away)
Resistance (— away)

Takeaway The shares are about 7.3% above 59.38, a price buyers have stepped in at before. There is no ceiling to point to, because the stock is trading where it has not traded before and nobody has sold it at these levels. That floor has held 4 times, which is how it was spotted. If someone bought at today's price and sold if it dropped through the level below, they would be about 4.4% out of pocket. That is all this figure means — an illustration of the risk, not a price to sell at.

Levels are computed from price structure. They describe where the engine locates support and extension — they are not targets, and not advice.

Ichimoku Cloud (Adaptive)

Daily cloudPrice INSIDE the cloud | periods 5/13/27 (51% of classic 9/26/52)
LinesTenkan/Kijun BULL | cloud twist BULL
Cloud thickness82% percentile (thick — substantial structure)
Chikou spanAbove price from 26 periods ago
Weekly cloudPrice ABOVE the weekly cloud (context only, not scored)

Takeaway The stock is trading inside its cloud — a shaded band drawn from several of its own moving averages, currently 62.44 to 64.04. Inside the band those averages disagree with each other, so the indicator is not saying much either way. Its shorter-term averages point the other way, so this is a mixed reading rather than a clear one. The band is unusually wide at the moment, so it marks a broad zone rather than a single level.

Trailing returns

21 days +11.9%
63 days +12.8%
126 days +4.7%
252 days +38.7%
Below 252d high3.3%

Trend context

PositionAbove trend
ExtensionExtended
Trend slopeRising
Direction of travelHolding its deviation

Takeaway Positive Kalman trend with moderate extension; constructive for momentum but watch entry risk.

Volatility

State No recent compression
Current band width11.7% of price
Recent tightest11.7% (0 sessions ago, narrower than 22.0% of its history)
Expansion since1.00×
Band 59.43 — 66.78

Takeaway Lately this share price has been swinging around inside a range roughly 12% wide. That is normal for this stock, so there is nothing unusual to read into it either way.

Historical trends

0255075100Share price 56.70–65.312026-07-032026-08-12
Position Health Business Conviction Share price

History begins when the site started recording, not when the company listed, so a short line means a short record and nothing more.

Who's Tradingthe flow behind the priceTop ↑

Insider activity

ActivityNo filings in the window
Buy filings0
Sell filings0

Open-market Form 4 purchases and sales over the last 75 days, read from SEC EDGAR Form 4. Grants, option exercises, gifts and shares withheld for tax are excluded — they are compensation mechanics, not a decision to buy or sell. Reported Form 4 activity. Brown Bear tested insider cluster-buying as a return signal and rejected it as era-unstable; shown as fact, not signal.

Volume confirmation

Volume-price trend Above its signal line
Confirmation Marginal

No absorption or distribution event in the recent window.

Takeaway Slightly more shares change hands on rising days than on falling ones, but the gap is too small to read anything into.

Options Positioning

No binary-event flag

BMY: no binary-event flag. Near IV 25%, far IV 28% (ratio 0.91), implied move 3.2%.

Implied volatility 25% near (9d) · 28% far (65d)
Term structure 0.91× near/far
Historical volatility 23%
Implied vs historical 1.10×
Implied move ±3.2% by 2026-08-21
Implied move vs ATR 0.37×
Skew Flat (1.09×)
Call wall 65.00 (+2.0% away)
Put wall 61.00 (-4.2% away)
Gamma pin 62.50

Takeaway Insuring against a move in this stock costs less for the next few weeks than for the next few months, which is the normal state of affairs and suggests no particular date is worrying anyone. Options traders are positioned for a move of around 3.2% in either direction by 2026-08-21.

Chain as at 2026-08-12. This is a risk read on whether a specific event is being priced — not a directional view.

Context & Methodthe record, and how it was builtTop ↑

Relative Rotation

ImprovingLeadingLaggingWeakeningvs sectorvs SPYsector vs SPYRS-Ratio →RS-Momentum →

Repair Attempt

Rotation health 42.0/100; Negative Rotation.

Rotation health 42.0
Rotation strength 76.4
LegQuadrantRS-RatioRS-Mom
Stock vs sector Weakening 103.5 91.7
Stock vs SPY Lagging 98.1 82.6
Sector vs SPY Improving 86.4 102.1

Direction of travel: North-West / early recovery

Position only. Brown Bear's RRG redesign programme is closed — five constructions, none beat an appropriate null — so this section describes where the name sits, and is not a signal.

News Headlines

  1. Loading headlines\u2026

Headlines are supplied by third-party feeds and are not written, ranked or interpreted by Brown Bear. They feed no score on this page.

Detailed Scoring

Positive signals

  • Piotroski F-score 7/9 (+20.0)
  • Gross margin quality: 71.7% (+18.9)
  • ROIC quality: 16.8% (+10.1)
  • FCF margin quality: 29.4% (+19.6)
  • ROIC improving by 26.2 pts (+10.0)
  • FCF margin improving by -2.1 pts (+-3.0)
  • High earnings quality (accrual ratio -0.079) (+5.0)
  • Track 1: 20-day momentum acceleration 0.04 (+3.0)
  • Track 1: bullish DI spread 20.5 (+5.0)
  • Track 1: ADX 69.2 and rising (+10.0)
  • Track 1: relative momentum rank 0.76 (+3.5)
  • Track 1: Hidden Bullish MACD divergence (+15.0)
  • Track 1: EMA20 reclaim distance 1.3% (+7.0)
  • Track 1: EMA20 slope improving 1.3% (+3.3)
  • Track 1: VPT strength 0.04 (+0.8)
  • Track 1: price above EMA50 by 5.1% (+3.2)
  • Track 1: EMA50 slope improving 3.3% (+3.0)
  • Track 1: EMA50 support proximity 5.1% (+0.8)
  • Track 1: Bollinger position 0.58 (+3.4)

Negative signals

  • Track 1: weak volume confirmation (0.49x average)
  • Relative strength versus sector deteriorating
  • Track 1: MACD histogram deteriorating (-0.44)
  • Track 1: weak MACD line/signal structure (-8.0)
  • Track 1: MACD slope deteriorating (-3.0)
  • Track 1: RSI deterioration/extension 60.8, 5-day change -4.6
  • Below-average Altman Z-score (2.37)

Chase risk is not elevated for this name, so extension penalties are omitted from the negative signals above.